Pharmacology, Toxicology and Pharmaceutical Science
Diseases
100%
Cross-Sectional Study
91%
Malignant Neoplasm
74%
Prevalence
63%
Antiinfective Agent
61%
Diabetes Mellitus
52%
Antibiotics
50%
Warfarin
48%
Antimicrobial Resistance
45%
Infection
37%
Cardiovascular Disease
37%
Bioavailability
34%
Global Disease Burden
33%
microRNA
33%
Tablet
31%
Adverse Event
30%
Antioxidant
30%
Cohort Study
27%
Nanoparticle
27%
Comorbidity
26%
Inflammation
25%
Anti-Inflammatory Drug
24%
Pharmacokinetic
24%
Retrospective Study
22%
Side Effect
22%
Chitosan
21%
Coronavirinae
21%
Community Pharmacy
21%
Pandemic
20%
Anticoagulant Agent
19%
Observational Study
19%
SARS Coronavirus
18%
Vancomycin
18%
Breast Cancer
18%
Combination Therapy
17%
Pharmacotherapy
17%
Chronic Disease
17%
Neoplasm
16%
Drug Release
16%
Cyclodextrin
16%
Clinical Trial
15%
Drug Interaction
15%
Drug Delivery System
14%
Nanoemulsion
14%
FDA Adverse Event Reporting System
14%
Non Insulin Dependent Diabetes Mellitus
13%
Hydroxychloroquine
13%
Pharmacy Practice
13%
Resveratrol
13%
Chemotherapy
13%
Cross Sectional Study
13%
Syndrome
13%
Differential Scanning Calorimetry
13%
Parkinson's Disease
13%
Reverse Phase High Performance Liquid Chromatography
13%
Nanomaterial
13%
Congestive Heart Failure
13%
Transcription Factor Nrf2
12%
Surgical Prophylaxis
12%
Curcumin
12%
Adverse Drug Reaction
12%
Surgical Infection
12%
Hemoglobin A1c
12%
Dosage Form
12%
Pterostilbene
12%
Eudragit
12%
Phytochemical
12%
Escherichia coli
11%
Randomized Controlled Trial
11%
Inflammatory Arthritis
11%
Rheumatoid Arthritis
11%
Drug-Drug Interaction
11%
Medication Error
11%
COVID-19 Vaccine
11%
Doxorubicin
11%
Piroxicam
10%
Gentamicin
10%
CYP2C9
10%
Scanning Electron Microscopy
10%
IC50
10%
Controlled Release
10%
Atrial Fibrillation
10%
Silibinin
10%
Dexibuprofen
10%
Favipiravir
10%
Rosuvastatin
10%
Diabetic Cardiomyopathy
10%
Liver Cell Carcinoma
10%
Nanocomposite
10%
Polypharmacy
10%
High Performance Liquid Chromatography
9%
Antidiabetic Agent
9%
Poloxamer
9%
Life Expectancy
9%
Superoxide Dismutase
9%
Infectious Agent
9%
Untranslated RNA
9%
Essential Oil
9%
Acinetobacter Baumannii
9%
Zeta Potential
9%
Nursing and Health Professions
Cross-Sectional Study
59%
Quality of Life
56%
Health Care Personnel
42%
Diseases
36%
Diabetes Mellitus
34%
Warfarin
26%
Antimicrobial Stewardship
26%
Systematic Review
18%
Medication Compliance
18%
Antimicrobial Resistance
16%
Tertiary Care Center
16%
Cohort Analysis
16%
Patient with Diabetes
15%
Antiinfective Agent
15%
Health Care Cost
15%
Rheumatoid Arthritis
13%
Inflammatory Arthritis
13%
Cost Effectiveness Analysis
13%
Prevalence
13%
Propensity Score
12%
Patient Compliance
11%
Intensive Care Unit
11%
Chronic Disease
11%
Meta Analysis
11%
Pharmacy Student
11%
Emergency Ward
11%
Blood Pressure
10%
Patient Attitude
10%
Health Care Utilization
10%
Health Care
10%
World Health Organization
10%
Patient with Type 2 Diabetes
9%
Cardiovascular Disease
9%
Medication Error
9%
General Practitioner
9%
Medication Therapy Management
9%
Primary Health Care
9%
Telemedicine
8%
Non Insulin Dependent Diabetes Mellitus
8%
Anticoagulant Therapy
8%
Odds Ratio
8%
Inferential Statistics
8%
Infection
7%
Drug Therapy
7%
Professional Standard
7%
Congestive Heart Failure
7%
Anticoagulant Agent
7%
Clinical Outcome
7%
Anticoagulation
7%
Comorbidity
7%
International Normalized Ratio
6%
Confidence Interval
6%
Polypharmacy
6%
Linear Regression Analysis
6%
Hemoglobin A1c
5%
Practice Guideline
5%
Multiple Linear Regression Analysis
5%
Malignant Neoplasm
5%
Hospital Readmission
5%
Hazard Ratio
5%
Logistic Regression Analysis
5%
Patient-Reported Outcome
5%
Self Care
5%
Stress Ulcer
5%
Resveratrol
5%
Breast Cancer
5%
Physical Disease by Body Function
5%
Medicine and Dentistry
COVID-19
38%
Malignant Neoplasm
27%
microRNA
23%
Diabetes
23%
Health Care Cost
23%
Global Disease Burden
22%
Diseases
20%
Diabetes Mellitus
19%
Cross Sectional Study
18%
Programmed Cell Death
17%
Cancer Therapy
16%
Tertiary Care
14%
Systematic Review
13%
Retrospective Cohort Study
12%
Maturity Onset Diabetes of the Young
12%
Metastatic Carcinoma
12%
Infection
12%
Cancer Cell
11%
Quality of Life
11%
Neoplasm
11%
Prevalence
11%
Cardiovascular Disease
11%
Drug Therapy
11%
Antiinfective Agent
10%
Breast Cancer
10%
Combination Therapy
9%
Patient with Type 2 Diabetes
9%
Chronic Disease
9%
Apoplexy
8%
Emergency Department
7%
Tumor Progression
7%
Pediatrics
7%
Hemoglobin A1c
7%
Patient with Diabetes
7%
Tocilizumab
7%
Antibiotic Resistance
7%
Odds Ratio
7%
Disability Adjusted Life Years
7%
Cardiovascular System
7%
COVID-19 Vaccination
6%
Primary Health Care
6%
Prostate Cancer
6%
Hepatocellular Carcinoma
6%
Exosome
6%
Complementary and Alternative Medicine
6%
Ophthalmology
6%
Lung Cancer
6%
Epithelial Mesenchymal Transition
6%
Life Expectancy
6%
Phytochemical
6%
Antibiotics
6%
Public Health
6%
Health Care
6%
Propensity Score Matching
6%
Insulin Resistance
5%
Cell Death
5%
Health Care Management
5%
Polycystic Ovarian Syndrome
5%
Pediatrics Patient
5%
Medicine
5%
Retrospective Study
5%
Acute Myeloid Leukemia
5%
Pathogen
5%
Angiogenesis
5%
Autophagy
5%
Patient Care
5%
Polycystic Ovary Syndrome
5%
Stress Ulcer
5%
Gene Therapy
5%
Cancer
5%
Klebsiella pneumoniae
5%